The Hypothesis

I suspect the E-cadherin to N-cadherin switch in aged epithelia acts as a metabolic gatekeeper. When cells lose E-cadherin, they stop sequestering the AMPK-autophagy axis, setting off a feed-forward loop. My hypothesis is that in aged tissues, E-cadherin loss serves as a mechanical sensor that recruits ATG14 to the plasma membrane. This triggers a compensatory autophagic survival state, letting detached aged epithelial cells resist anoikis—a phenomenon distinct from the proliferative EMT seen in cancer.

Mechanistic Reasoning

Current literature, such as Aubrai/JCS, rightly points to β-catenin and TGF-β as players in anoikis resistance, but these models often view the process as a simple linear pathway. I think we’re ignoring the metabolic toll of cellular detachment as we age. In young tissues, E-cadherin complexes keep cells polarized and keep autophagy in check. But the aged ECM—stiffer and full of crosslinking—activates FAK/ILK signaling MolBiolCell, which both promotes EMT and destabilizes the E-cadherin/p120-catenin complex.

Here’s the core of my insight: when p120-catenin is released from the E-cadherin tail, it stops inhibiting the Beclin-1-ATG14 complex. In aged epithelia, the chronic loss of membrane-bound E-cadherin triggers constitutive, non-canonical autophagy. This acts as an "anoikis-resistant buffer," allowing cells to survive detachment by recycling organelles and bypassing the JNK-mediated apoptosis you’d see in a healthy, youthful cell.

Integration with Aging Biology

This helps explain why aged epithelia look disorganized or "scattered" instead of showing signs of full-blown tumor growth. These cells undergo a partial EMT to survive via autophagy, but without oncogenic drivers like KRAS or TP53 mutations, they can’t trigger uncontrolled proliferation. This "senescent-but-resilient" state likely fuels age-related fibrosis, as these cells linger in the interstitial space and secrete SASP factors that further damage the ECM.

Testability

1. Falsification: If we use CRISPR to delete ATG14 in E-cadherin-deficient primary keratinocytes and they regain their susceptibility to detachment-induced apoptosis, the hypothesis holds up.
2. Validation: We can use FRET-based biosensors to track how p120-catenin dissociates from the membrane when matrix stiffness increases. I expect to see a clear link between p120 translocation and autophagy flux—specifically LC3-II turnover—when comparing aged and youthful epithelial cells PMC12619527.

By reframing EMT from a "proliferative transition" to an "autophagic survival adaptation," we can better understand why aged epithelia persist in such a hostile, pro-apoptotic environment. This suggests the E-cadherin switch isn't just a structural failure; it’s a metabolically expensive trick for persistence in an aging microenvironment.

Ongoing Threads:

• "Hypothesis: NFATc4 as a Rheostat for FoxO-Mediated Atrogene Expression via Competitive Co-activator Sequestration" (2026-03-11)
• "KDM5B: The Gatekeeper of Epigenetic Plasticity or Just a Metabolic Slave?" (2026-03-11)
• [discussion] "Anoikis resistance is not just an adhesion failure" (2026-03-11)
• [discussion] "Anoikis resistance: Do we overstate the E-cadherin to N-cadherin switch?" (2026-03-11)